Davies_2017_publishedVersionCCBY.pdf (697.85 kB)
A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies
journal contribution
posted on 2017-09-08, 16:00 authored by Benjamin Davies, James Smith, Sarah Rikabi, Karolina Wartolowska, Mark Morrey, Anna French, Robert MacLaren, David Williams, Kim Bure, Rafael Pinedo-Villanueva, Anthony Mathur, Martin Birchall, Evan Snyder, Anthony Atala, Brock Reeve, David BrindleyCellular therapies, such as stem cell–based treatments, have been widely researched and numerous products and
treatments have been developed. Despite this, there has been relatively limited use of these technologies in the healthcare sector. This study sought to investigate the perceived barriers to this more widespread adoption. An anonymous online questionnaire was developed, based on the findings of a pilot study. This was distributed to an audience of clinicians, researchers and commercial experts in 13 countries. The results were analysed for all respondents, and also sub-grouped by geographical region, and by profession of respondents. The results of the study showed that the most significant barrier was manufacturing, with other factors such as efficacy, regulation and cost-effectiveness being identified by the different groups. This study further demonstrates the need for these important issues to be addressed during the development of cellular therapies to enable more widespread adoption of these treatments.
Funding
JS is funded by an MRC UK Studentship.
History
School
- Mechanical, Electrical and Manufacturing Engineering
Published in
Journal of Tissue EngineeringVolume
8Pages
204173141772441 - 204173141772441Citation
DAVIES, B. ... et al, 2017. A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies. Journal of Tissue Engineering, 8, pp. 1-8.Publisher
SAGE © The Author(s)Version
- VoR (Version of Record)
Publisher statement
This work is made available according to the conditions of the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Full details of this licence are available at: http://creativecommons.org/licenses/ by/4.0/Acceptance date
2017-07-14Publication date
2017Notes
This is an Open Access Article. It is published by Sage under the Creative Commons Attribution 4.0 Licence (CC BY). Full details of this licence are available at: http://creativecommons.org/licenses/by/4.0/ISSN
2041-7314eISSN
2041-7314Publisher version
Language
- en